“Lupus mimics other diseases in your body and the community still doesn’t understand what it is,” says Daniella Djan who is living with the condition.
Djan’s life changed irrevocably when she was 18-years-old and diagnosed with systemic lupus erythematosus, commonly known as lupus. That was 15 years ago.
What is Lupus?
Lupus – a Latin word meaning wolf – is an autoimmune disease where the immune system attacks the body’s own cells.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.